Coca-Cola Europacific Partners plc
CCEP- Exchange
- Nasdaq
- Industry
- Bottled & Canned Soft Drinks & Carbonated Waters
- SEC CIK
- 0001650107
No open-market purchases or sales by Coca-Cola Europacific Partners plc insiders were filed in the last 90 days; 582 institutions reported holding it in 13F filings for Q2 2026, worth $15.4B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Coca-Cola Europacific Partners plc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 448
- +18 vs. Q2 2023
- Shares held
- 138.9M
- +2.83M (+2.1%) vs. Q2 2023
- Total value
- $8.68B
- −$42.9M (−0.5%) vs. Q2 2023
- New holders
- 53
- 189 more added
- Sold out
- 35
- 125 more reduced
4 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCEP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 582 | $15.4B |
| Q1 2026 | 578 | $14.3B |
| Q4 2025 | 569 | $14.4B |
| Q3 2025 | 525 | $14.0B |
| Q2 2025 | 544 | $13.9B |
| Q1 2025 | 564 | $13.5B |
| Q4 2024 | 534 | $11.2B |
| Q3 2024 | 528 | $11.0B |
| Q2 2024 | 501 | $10.5B |
| Q1 2024 | 491 | $10.0B |
| Q4 2023 | 479 | $9.55B |
| Q3 2023 | 448 | $8.68B |
| Q2 2023 | 434 | $8.73B |
| Q1 2023 | 389 | $8.07B |
| Q4 2022 | 395 | $7.52B |
| Q3 2022 | 373 | $5.66B |
| Q2 2022 | 364 | $6.80B |
| Q1 2022 | 365 | $6.47B |
| Q4 2021 | 365 | $7.39B |
| Q3 2021 | 368 | $7.30B |
| Q2 2021 | 372 | $7.87B |
| Q1 2021 | 343 | $6.90B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Coca-Cola Europacific Partners plc; share changes are against Q2 2023.